315 related articles for article (PubMed ID: 23927683)
1. Development of Mycobacterium tuberculosis whole cell screening hits as potential antituberculosis agents.
Cooper CB
J Med Chem; 2013 Oct; 56(20):7755-60. PubMed ID: 23927683
[TBL] [Abstract][Full Text] [Related]
2. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
Manjunatha UH; Smith PW
Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Tuberculosis drug discovery and emerging targets.
Mdluli K; Kaneko T; Upton A
Ann N Y Acad Sci; 2014 Sep; 1323():56-75. PubMed ID: 24920100
[TBL] [Abstract][Full Text] [Related]
5. In silico analyses for the discovery of tuberculosis drug targets.
Chung BK; Dick T; Lee DY
J Antimicrob Chemother; 2013 Dec; 68(12):2701-9. PubMed ID: 23838951
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic screening as a strategic component of drug discovery programs targeting novel antiparasitic and antimycobacterial agents: an editorial.
Butera JA
J Med Chem; 2013 Oct; 56(20):7715-8. PubMed ID: 23927625
[TBL] [Abstract][Full Text] [Related]
7. Improving the tuberculosis drug development pipeline.
Evangelopoulos D; McHugh TD
Chem Biol Drug Des; 2015 Nov; 86(5):951-60. PubMed ID: 25772393
[TBL] [Abstract][Full Text] [Related]
8. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
Goldman RC
Tuberculosis (Edinb); 2013 Nov; 93(6):569-88. PubMed ID: 24119636
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets.
Hudson SA; McLean KJ; Munro AW; Abell C
Biochem Soc Trans; 2012 Jun; 40(3):573-9. PubMed ID: 22616869
[TBL] [Abstract][Full Text] [Related]
10. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.
Guillemont J; Meyer C; Poncelet A; Bourdrez X; Andries K
Future Med Chem; 2011 Sep; 3(11):1345-60. PubMed ID: 21879841
[TBL] [Abstract][Full Text] [Related]
11. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
12. Novel and revisited approaches in antituberculosis drug discovery.
Herrmann J; Rybniker J; Müller R
Curr Opin Biotechnol; 2017 Dec; 48():94-101. PubMed ID: 28427007
[TBL] [Abstract][Full Text] [Related]
13. Computational medicinal chemistry for rational drug design: Identification of novel chemical structures with potential anti-tuberculosis activity.
Koseki Y; Aoki S
Curr Top Med Chem; 2014; 14(1):176-88. PubMed ID: 24236720
[TBL] [Abstract][Full Text] [Related]
14. The future for early-stage tuberculosis drug discovery.
Zuniga ES; Early J; Parish T
Future Microbiol; 2015; 10(2):217-29. PubMed ID: 25689534
[TBL] [Abstract][Full Text] [Related]
15. Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon.
Bhat ZS; Rather MA; Maqbool M; Ahmad Z
Biomed Pharmacother; 2018 Jul; 103():1733-1747. PubMed ID: 29864964
[TBL] [Abstract][Full Text] [Related]
16. Challenges and opportunities in developing novel drugs for TB.
Kaneko T; Cooper C; Mdluli K
Future Med Chem; 2011 Sep; 3(11):1373-400. PubMed ID: 21879843
[TBL] [Abstract][Full Text] [Related]
17. Drug discovery in tuberculosis. New drug targets and antimycobacterial agents.
Campaniço A; Moreira R; Lopes F
Eur J Med Chem; 2018 Apr; 150():525-545. PubMed ID: 29549838
[TBL] [Abstract][Full Text] [Related]
18. Increasing the structural coverage of tuberculosis drug targets.
Baugh L; Phan I; Begley DW; Clifton MC; Armour B; Dranow DM; Taylor BM; Muruthi MM; Abendroth J; Fairman JW; Fox D; Dieterich SH; Staker BL; Gardberg AS; Choi R; Hewitt SN; Napuli AJ; Myers J; Barrett LK; Zhang Y; Ferrell M; Mundt E; Thompkins K; Tran N; Lyons-Abbott S; Abramov A; Sekar A; Serbzhinskiy D; Lorimer D; Buchko GW; Stacy R; Stewart LJ; Edwards TE; Van Voorhis WC; Myler PJ
Tuberculosis (Edinb); 2015 Mar; 95(2):142-8. PubMed ID: 25613812
[TBL] [Abstract][Full Text] [Related]
19. Next-generation antimicrobials: from chemical biology to first-in-class drugs.
Ang ML; Murima P; Pethe K
Arch Pharm Res; 2015 Sep; 38(9):1702-17. PubMed ID: 26259630
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of novel drug targets in Mycobacterium tuberculosis.
Singh V; Mizrahi V
Drug Discov Today; 2017 Mar; 22(3):503-509. PubMed ID: 27649943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
